@tedvickey posted this great quote today:
We’re already overwhelmed with data. What we need is information, knowledge and wisdom.
- Dr. John Halamka, CIO of Beth Israel
Halamka gets to the heart of what challenges so many of the health apps currently available to consumers. They collect a lot of data. Sometimes, they make pretty dashboards with that data. But what is consistently missing is the knowledge and wisdom of what that data means, what can be done with it and how.
That’s what scientific experts bring to the table. Our years of training and experience are exactly about how to take all that data (believe me, we collect insane amounts of it in every study) and use it to improve – to make weight loss programs better, to improve the feedback that program participants get, to IMPROVE OUTCOMES.
There are a lot of apps that have been created by some smart teams. Many of them have brilliant programmers. But most of them have never run a behavior change program. They haven’t piloted a new approach and had it deliver unprecedented results (or had it bomb terribly – an equally valuable learning experience).
Yes, those folks can go to PubMed and read all about the research that my colleagues and I have spent decades doing. If they’re lucky, they can find a stellar systematic review and meta-analysis that sums it all up in under 4,000 words. But doing isn’t reading. I can read every Berkshire Hathaway Annual Report, but that doesn’t make me the Oracle of Omaha and I can’t imagine someone suggesting to you that taking investment advice from me is a sound financial decision. So why are we putting our health data and the opportunities it provides for information, knowledge and wisdom in the hands of amateurs?
I’ve been taking time away from the lab each day for the past few weeks to learn web application development. I’ll post more about the what and why another time. This week the connection between my program and my lab work came together in another way.
I’m enrolled in class at Starter School (formerly called The Starter League and Code Academy), which sits with-in 1871, Chicago’s premiere start-up incubator and co-work space. Starter School is a 9-month program that teaches the coding, design and entrepreneurship to build software and start companies. (If you want to learn more about what makes this program unique and awesome, check out this WSJ article and the interview with my classmate Chance). I’m only enrolled in the first 3 months which focuses on coding and programming. We do start diving into entrepreneurship and it has been an eye opening experience for me.
Our starting point in those classes was The Lean Start-up by Eric Ries and the How to Build a Startup series on Udacity with Steve Blank. I wish everyone in academic research would watch Blank’s first lesson (which is done in three videos). I see a number of parallels to academia worth that I’ve been noodling based only on my teaser introduction to the world of Lean Start-ups.
“Start-ups are not small version of big companies.” The labs of our senior established faculty (the people with endowed chairs who have four R01s (or used to) at a time) seem like big companies. They have well established systems for moving their research forward. Processes that they’ve built over years, staff that execute details. But the lab of a newly hired assistant professor can’t operate like a smaller version of that. I don’t think it should. In the current funding climate, I think allowing (and encouraging) junior faculty to act and think more like start-ups would increase their likelihood of success and increase their ability to innovate.
In recent years, people within and outside the research community have criticized our grant review process as not really promoting the kinds of innovations and leaps we need to truly tackle our goals (as a cancer researcher, these are often written and framed within our failure to “win the war on cancer”). These commentaries assert that we don’t make the kinds of leaps we hope to make, but instead make small incremental advances in our science. I’ve heard time and again from my peers about the great novel idea they had that got a response of “No one will fund YOU to do that. You’re too unproven” in some form or another from mentors or peer reviewers. These faculty are like entrepreneurs – they have hypotheses about what will work and they need to test them (in academia, we call this getting pilot data). The problem is that we tend to be resistant to pivoting when the pilot data doesn’t play out. Our resources are so limited that the pilot data is too often seen as a means of showing we can do “anything” rather than “this thing”. Hypothesis testing in the lean start-up is expected to lead to lots of hypothesis rejection or modification until the hypotheses left to test are so low risk (e.g., should the logo be Pantone 165 or 166?) that spending time and money to test them may not be necessary to launch.
Lean start up also aligns nicely with the calls from some of our best scientists to think about alternatives to the randomized clinical trial. Randomized trials are expensive and time consuming and not conducive to early data that suggests the intervention/product won’t work in the “real world.” When data to reject “real world applicability” comes to a lean start-up, it MUST re-evaluate the path. But a junior faculty member trying to build a lab doesn’t have the ability to pivot a randomized trial or it might be the last one she’s funded to run. She needs to deliver the study she was funded to. A greater flexibility in the study designs we let drive our decision making would benefit our field. We would also benefit from giving our faculty and their NIH program officers more flexibility to adapt and make changes mid-study.
Opening academia up to new approaches to building a research program/lab and new ways of thinking seems at least worth contemplating given our tight funding climate. I’d love to hear others’ thoughts on this!
This was a big week for the rapidly advancing field of cancer survivorship science.
Work I did with colleagues at Washington University in St Louis was released ahead of print in the journal Cancer Causes and Control. Eight ways to stay healthy after cancer is a patient-focused set of messages, with an accompanying brochure, on staying healthy after a cancer diagnosis. Focused on choices patients can make it includes, avoiding tobacco smoke (including secondhand), maintaining a healthy weight, being physically active, a healthy diet, alcohol in moderation (if at all), social support and regular health check-ups.
Also out this week are the NCCN practice guidelines for survivorship. More focused on what health care providers need to know after treatment ends, though acknowledging the role that family members and caregivers play, the NCCN guidelines center on eight areas as well: anxiety and depression, sleep disorders, cognitive function, fatigue, exercise, pain, sexual function, and immunizations and immune function.
Both guidelines acknowledge that dissemination to stakeholders and implementation into routine care remain significant challenges.
I’m thrilled to announce that on April 1, I will officially join the faculty at Loyola University Chicago’s Stritch School of Medicine in the Department of Public Health Sciences.
Loyola University Chicago has an outstanding commitment to reducing the global burden of preventable disease, improving international health, and decreasing health disparities. The community surrounding the Stritch School of Medicine disproportionately suffers from high rates of obesity and preventable chronic diseases, including heart disease and cancer.
The Public Health Programs at Loyola are truly multidisciplinary, drawing from faculty in medicine, nursing, ethics, health policy, environmental health, statistics, social work and communication.
This move will allow my lab to continue its commitment to cancer prevention and survivorship, improving health outcomes in medical and community settings and addressing the needs of the underserved.
There are some great books and blogs out there making compelling cases for scientists to get more engaged in policy. Changes in elected officials lead to changes in committee representation (not just leadership, but also membership) that has the potential to shape scientific and health policy. PandoDaily has a nice round-up of the changes on the House Committee on Science, Space and Technology that might result from the election.
I’ll be back on the Dr. Oz Show today talking about ovarian cancer prevention with Dr. Oz and Dr. Diljeet Singh. As with many cancers, we talked about the risk of being overweight. My thanks to Dr. Oz and his team for inviting me to talk about this important topic!
As a cancer researcher, I often get asked to talk about how our choices (to exercise or not, to eat vegetables or Twinkies) influence our health. And what most people expect me to talk about, and I do, are the benefits of those choices on disease and mortality endpoints. But I also always talk about the QUALITY of life benefits – not just the QUANTITY of life benefits.
The quality of life benefits are real. I should know, as one of my earliest published research articles was on the benefit of exercise for quality of life.
It is great to see the dialog about exercise starting to change – to get people to focus on the immediate benefits of exercise. You feel better. You sleep better. Kudos to Jane Brody for highlighting it this week in the NY Times.
If you need some more reasons to exercise today, hop over to Twitter and check out the #reasontoexercise tag from my colleague Dr. Sherry Pagoto.